Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CorMedix Inc.CRMD · Entity 5280 | Exec VP of Tech Operations | January 11, 2021 | January 14, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CorMedix Inc.
Report date January 11, 2021 · Filed January 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $8.32 · Expires 2031-01-11 | Direct | 140,000 |
Reported balance
After 2021-01-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-01-11 · Grant · Acquired 140,000 · Balance 140,000 F1: These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $5.63 · Expires 2030-05-11 | Direct | 37,500 |
Reported balance
Holding disclosure · report date 2021-01-11 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 37,500 F2: These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $4.08 · Expires 2030-05-11 | Direct | 37,500 |
Reported balance
Holding disclosure · report date 2021-01-11 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 37,500 F2: These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $5.63 · Expires 2030-02-25 | Direct | 24,764 |
Reported balance
Holding disclosure · report date 2021-01-11 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 24,764 F3: These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $8.30 · Expires 2029-01-10 | Direct | 7,830 |
Reported balance
Holding disclosure · report date 2021-01-11 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 7,830 F4: These options were granted on 1/10/2019. These options vest, subject to continued employment, as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones. These options include options to purchase an aggregate of 1,575 shares that are subject to vesting 50% on January 10, 2021 and 50% on January 10, 2022. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $10.90 · Expires 2027-03-01 | Direct | 6,600 |
Reported balance
Holding disclosure · report date 2021-01-11 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 6,600 F5: These options vested upon the achievement of certain performance milestones. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $7.60 · Expires 2024-11-14 | Direct | 2,000 |
Reported balance
Holding disclosure · report date 2021-01-11 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 2,000 F6: These options vested upon the achievement of certain milestones. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $16.25 · Expires 2025-07-28 | Direct | 3,000 |
Reported balance
Holding disclosure · report date 2021-01-11 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 3,000 F7: These options are fully vested. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $12.55 · Expires 2026-03-08 | Direct | 40,000 |
Reported balance
Holding disclosure · report date 2021-01-11 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 40,000 F8: 3,000 of these options vested monthly over four years, beginning on March 9, 2016, 4,000 vest upon the achievement of a certain milestone, subject to continued employment, and the rest vested upon the achievement of certain milestones. These options are fully vested. |
| Common StockSEC Table I · non-derivative | Direct | 96,878 |
Reported balance
Holding disclosure · report date 2021-01-11 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 96,878 |
Filing footnotes · ownership attribution and instrument terms
F1: These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.
F2: These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
F3: These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
F4: These options were granted on 1/10/2019. These options vest, subject to continued employment, as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones. These options include options to purchase an aggregate of 1,575 shares that are subject to vesting 50% on January 10, 2021 and 50% on January 10, 2022.
F5: These options vested upon the achievement of certain performance milestones.
F6: These options vested upon the achievement of certain milestones.
F7: These options are fully vested.
F8: 3,000 of these options vested monthly over four years, beginning on March 9, 2016, 4,000 vest upon the achievement of a certain milestone, subject to continued employment, and the rest vested upon the achievement of certain milestones. These options are fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 11, 2021 Filed Jan 14, 2021 02:39 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 140,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002078 · doc4.xml · derivative · entry 2 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 00:06 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 10,000 | $4.35 | $43,460.00 |
DisclosureSEC source: 0001213900-20-022579 · doc4.xml · nonDerivative · entry 3 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,878 Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 00:06 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 7,500 | $4.14 | $31,050.00 |
DisclosureSEC source: 0001213900-20-022579 · doc4.xml · nonDerivative · entry 2 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,878 Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 00:06 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 10,000 | $4.16 | $41,600.00 |
DisclosureSEC source: 0001213900-20-022579 · doc4.xml · nonDerivative · entry 1 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,378 Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:44 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 37,500 | $4.08 Strike: $4.08 | $153,000.00 |
DisclosureSEC source: 0001213900-20-012021 · doc4.xml · derivative · entry 3 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2030-05-11 F1 · derivative.exercise_date: These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:44 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 37,500 | $5.63 Strike: $5.63 | $211,125.00 |
DisclosureSEC source: 0001213900-20-012021 · doc4.xml · derivative · entry 2 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2030-05-11 F1 · derivative.exercise_date: These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:43 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 24,764 | $5.63 Strike: $5.63 | $139,421.32 |
DisclosureSEC source: 0001213900-20-004975 · doc4.xml · derivative · entry 2 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,764 Underlying: Common Stock · 24,764 shares Expires 2030-02-25 F1 · derivative.exercise_date: These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| March 26, 2019 Filed Mar 27, 2019 20:12 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 5,000 | $7.73 | $38,650.00 |
DisclosureSEC source: 0001654954-19-003466 · section16.xml · nonDerivative · entry 1 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,378 F1 · balance_after: The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 20:09 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 15,000 | $1.69 | $25,350.00 |
DisclosureSEC source: 0001654954-19-003244 · section16.xml · nonDerivative · entry 1 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,890 Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 21:21 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 45,000 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001654954-19-000385 · section16.xml · derivative · entry 2 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2029-01-10 F1 · derivative.exercise_date: These options were granted on 1/10/2019. These options vest, subject to continued employment, as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:02 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionRestricted Stock Units · Derivative | 18,029 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-000079 · section16.xml · derivative · entry 2 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,029 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vested 50% on December 31, 2017 and December 31, 2018, subject to continued employment. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:02 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 18,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-000079 · section16.xml · nonDerivative · entry 1 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vested 50% on December 31, 2017 and December 31, 2018, subject to continued employment. Read SEC document |
| November 29, 2018 Filed Nov 30, 2018 21:04 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 250,000 | $1.45 | $363,150.00 |
DisclosureSEC source: 0001654954-18-013406 · section16.xml · nonDerivative · entry 1 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,861 F1 · price: Represents the weighted average purchase price of the shares purchased ranging from a low of $1.4150 to a high of $1.47. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:00 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 45,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-001714 · section16.xml · derivative · entry 2 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-02-16 F1 · derivative.exercise_date: The options vest 25% on the date of grant (2/16/2018), and 25% on the first, second and third anniversaries of the date of grant, subject to Optionee's continued service through such date. Read SEC document |
| December 31, 2017 Filed Mar 22, 2018 20:02 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionRestricted Stock Units · Derivative | 18,028 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-002933 · section16.xml · derivative · entry 2 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,029 Underlying: Common Stock · 18,028 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vested 50% on December 31, 2017 and 50% will vest on December 31, 2018, subject to continued employment. Read SEC document |
| December 31, 2017 Filed Mar 22, 2018 20:02 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 18,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-002933 · section16.xml · nonDerivative · entry 1 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vested 50% on December 31, 2017 and 50% will vest on December 31, 2018, subject to continued employment. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:08 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 20,833 | $0.48 | $9,999.84 |
DisclosureSEC source: 0001654954-17-011649 · section16.xml · nonDerivative · entry 1 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,833 F1 · date: Purchase was contracted on November 17, 2017, but not closed until December 12, 2017. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:01 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 100,000 | $0.00 Strike: $2.18 | $0.00 |
DisclosureSEC source: 0001354488-17-000385 · issuerdirect_section16.xml · derivative · entry 1 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-03-01 F1 · shares: The option vests based on certain performance milestones, subject to continued employment. The option will be forfeited if such milestones are not met by certain dates. F1 · derivative.exercise_date: The option vests based on certain performance milestones, subject to continued employment. The option will be forfeited if such milestones are not met by certain dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.